Landos biopharma inc.

Major-Pharmaceuticals

LABP


1800 Kraft Drive
Blacksburg , VA 24060

Executive/
Director

Price

  • Last Close
  • $ 0.31
    $ -0.02 -6.06 %
    May 25, 2023
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 193,831
  • Market Cap Full
  • $ 1M
  • Shares Outstanding
  • 3.1M
    Nov 3, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - - - - -69.3% -40.4% - -
Q2 - - - - - 19.9% -50.6% 4% - -
Q3 - - - - - 26.4% -10.7% - - -
Q4 - - - - - -67.1% -23.1% - - -
J F M A M J J A S O N D
2025 - - - - - - - - - - - -
2024 - - - - - - - - - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%0%0%0%-90%-38%0%0%

Earnings

2021 2022 2023
Q1 -0.38 -0.37 -0.90
Q2 0.12 -0.28 -0.63
Q3 -0.32 -0.2 -0.94
Q4 -0.44 -1.30 -
A -1 -1 -2.47

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2021 2022 2023
Mar - 40.3 31.2
Jun 40.1 40.3 31.2
Sep 40.1 40.3 3.1
Dec 40.2 40.3 3.1

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - 18 - - -
Total Asset Turnover - 0.2 - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 20.5 39 31 - -
Equity multiplier - - - - -